AzurRx BioPharma to Present at The Microcap Rodeo Winter Wonderland Conference
February 16, 2021 at 07:00 AM EST
DELRAY BEACH, Fla., Feb. 16, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (“AzurRx” or the “Company”) (NASDAQ: AZRX), a company specializing in the development of targeted non-systemic, recombinant therapies for gastrointestinal (GI) diseases, today announced that James Sapirstein, Chief Executive Officer, will present at The Microcap Rodeo Winter Wonderland Conference taking place virtually from February 16-19, 2021.
During his live virtual presentation on February 17th at 4:30 p.m., Eastern Time, Mr. Sapirstein will provide an overview of AzurRx’s business and clinical development programs and discuss anticipated 2021 milestones. Additionally, Mr. Sapirstein and members of the AzurRx management team will be participating in virtual one-on-one meetings with registered investors.
Details of the presentation are as follows:
About AzurRx BioPharma, Inc.
For more information:
AzurRx BioPharma, Inc.
Investor Relations contact:
LifeSci Advisors, LLC.